(S)-Bleximenib|CAS 2642321-69-3|DC Chemicals

Cas No.:	2642321-69-3
Chemical Name:	(S)-Bleximenib
Formula:	C₅₀H₆₆N₇O₉P
M.Wt:	940.07
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC80073	3α,7α-Dihydroxycoprostane	3α,7α-Dihydroxycoprostane is a metabolite of cholest-4-en-3-one-7α-ol.
DC80072	3α,7α-Dihydroxy-5β-cholestan-26-al	3α,7α-Dihydroxy-5β-cholestan-26-al is a nucleoside metabolite.
DC80070	3-Phospho-D-glycerate	3-Phospho-D-glycerate can be converted to 2-phospho-d-glycerate (2-PGA) via phosphoglycerate mutase.
DC80065	3-Methyldecane	3-Methyldecane is a fatty hydrocarbon volatile component of Ludwigia stolonifera. 3-Methyldecane can be used to study the metabolic differences in different parts of this aquatic plant.
DC73210	TH7528	TH7528 is a SAMHD1 inhibitor with IC50 of 4.5 μM/2.8 μM/2.6 μM against dGTP/Cl-F-ara-ATP/ara-CTP, respectively.
DC73203	DI-87	DI-87 ((R)-DI-87) is a highly potent, specific, orally bioavailable deoxycytidine kinase (dCK) inhibitor with IC50 of 3.15 nM.
DC72019	Fludarabine triphosphate trisodium	Fludarabine triphosphate (F-ara-ATP) trisodium, the active metabolite of Fludarabine, is a potent, noncompetitive and specific inhibitor of DNA primase, with an IC50 of 2.3 μM and a Ki of 6.1 μM. Fludarabine triphosphate trisodium inhibits DNA synthesis by blocking DNA primase and primer RNA formation. Fludarabine triphosphate trisodium inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis.
DC44975	5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine	5'-O-DMT-2'-O-TBDMS-N-Bz-Adenosine is an adenosine derivative and can be used as an intermediate for oligonucleotides synthesis.
DC41008	Fludarabine triphosphate	Fludarabine triphosphate (F-ara-ATP), the cytotoxic metabolite of Fludarabine phosphate, inhibits ribonucleotide reductase and DNA polymerase and ultimately leads to cellular apoptosis.
DC7762	RX-3117	RX-3117 is an orally available and potent DNA synthesis inhibitor with potential antineoplastic activity.